Formulation and Evaluation of Microspheres Based on Gelatin-Mucin Admixtures for the Rectal Delivery of Cefuroxime Sodium

Purpose: Swellable microspheres based on polymers or their admixtures are frequently employed as drug delivery systems to achieve a controlled release and site-specific targeting of the incorporated drug. The objective of the present study was to enhance the rectal delivery of cefuroxime sodium by entrapping it into water-swellable gelatin-mucin microspheres. Method: Cefuroxime sodium-loaded microspheres containing admixtures of gelatin and porcine mucin were prepared via an emulsification-crosslinking technique. The drug entrapment efficiency of the microspheres was evaluated in citrate/phosphate buffer (pH 7.4) while the swelling properties was evaluated in both simulated gastric fluid (SGF) without pepsin and simulated intestinal fluid (SIF) without pancreatin (pH 1.2). Release of cefuroxime sodium from the microspheres was evaluated in vitro in SIF and further evaluated in vivo after rectal administration to male Wistar rats. Result: Results obtained showed that a high entrapment efficiency, most notably manifested in microspheres formulated with equal portions of gelatin and mucin, led to a high release (up to 85 %) and also a high bioavailability of the incorporated drug. Formulations based on varying portions of gelatin and mucin also showed high drug loading efficiency which also resulted in high drug release in SIF within 3 h. Drug release from the different formulations was observed to be rapid and generally showed a biphasic pattern. The mean AUC was shown to be formulation-dependent with values of 168±1.93µg.h/ml for the control, 262±3.47 µg.h/ml for microspheres based on gelatine only and 328±2.55 µg.h/ml for microspheres formulated with equal parts of gelatin and mucin. Conclusion: The inclusion of S-mucin in the composition of the microspheres has an enhancer effect on the release and rectal bioavailability of cefuroxime sodium which may be exploited in the design of a rectal delivery system of the drug. Keywords: Gelatin-mucin microspheres, cefuroxime sodium, rectal bioavailability. Tropical Journal of Pharmaceutical Research Vol. 6 (4) 2007: pp. 825-83

Edible bio-based nanostructures: delivery, absorption and potential toxicity

The development of bio-based nanostructures as nanocarriers of bioactive compounds to specific body sites has been presented as a hot topic in food, pharmaceutical and nanotechnology fields. Food and pharmaceutical industries seek to explore the huge potential of these nanostructures, once they can be entirely composed of biocompatible and non-toxic materials. At the same time, they allow the incorporation of lipophilic and hydrophilic bioactive compounds protecting them against degradation, maintaining its active and functional performance. Nevertheless, the physicochemical properties of such structures (e.g., size and charge) could change significantly their behavior in the gastrointestinal (GI) tract. The main challenges in the development of these nanostructures are the proper characterization and understanding of the processes occurring at their surface, when in contact with living systems. This is crucial to understand their delivery and absorption behavior as well as to recognize potential toxicological effects. This review will provide an insight into the recent innovations and challenges in the field of delivery via GI tract using bio-based nanostructures. Also, an overview of the approaches followed to ensure an effective deliver (e.g., avoiding physiological barriers) and to enhance stability and absorptive intestinal uptake of bioactive compounds will be provided. Information about nanostructures potential toxicity and a concise description of the in vitro and in vivo toxicity studies will also be given.Joana T. Martins, Oscar L. Ramos, Ana C. Pinheiro, Ana I. Bourbon, Helder D. Silva and Miguel A. Cerqueira (SFRH/BPD/89992/2012, SFRH/BPD/80766/2011, SFRH/BPD/101181/2014, SFRH/BD/73178/2010, SFRH/BD/81288/2011, and SFRH/BPD/72753/2010, respectively) are the recipients of a fellowship from the Fundacao para a Ciencia e Tecnologia (FCT, POPH-QREN and FSE, Portugal). The authors thank the FCT Strategic Project PEst-OE/EQB/LA0023/2013 and the project "BioInd-Biotechnology and Bioengineering for improved Industrial and Agro-Food processes," REF.NORTE-07-0124-FEDER-000028, co-funded by the Programa Operacional Regional do Norte (ON.2-O Novo Norte), QREN, FEDER. We also thank to the European Commission: BIOCAPS (316265, FP7/REGPOT-2012-2013.1) and Xunta de Galicia: Agrupamento INBIOMED (2012/273) and Grupo con potencial de crecimiento. The support of EU Cost Action FA1001 is gratefully acknowledged